Literature DB >> 6805022

Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.

J Koerner, J B Appel.   

Abstract

Fifteen rats were trained to discriminate between the tryptamine hallucinogen psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine; 1.0 mg/kg) and saline in a two-lever choice task. Dose-response and time-response curves were obtained. The psilocybin cue generalized to psilocin (the dephosphorylated congener of psilocybin) and to the prototypical indoleamine hallucinogen LSD, but not to the phenylethylamine hallucinogen mescaline. These results indicate that the hallucinogenic effects of these drugs in humans may not be identical with their discriminative stimulus functions in animals, and that these four compounds may not be members of a single drug class. The term 'hallucinogen' may thus be a misnomer in the context of drug discrimination studies in nonhumans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805022     DOI: 10.1007/BF00435266

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  53 in total

1.  The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.

Authors:  I Creese; D R Burt; S H Synder
Journal:  Life Sci       Date:  1975-12-01       Impact factor: 5.037

2.  Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.

Authors:  B L Jacobs; M E Trulson; W C Stern
Journal:  Brain Res       Date:  1977-08-26       Impact factor: 3.252

3.  Comparison of psilocin with psilocybin, mescaline and LSD-25.

Authors:  A B WOLBACH; E J MINER; H ISBELL
Journal:  Psychopharmacologia       Date:  1962

4.  Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.

Authors:  A B WOLBACH; H ISBELL; E J MINER
Journal:  Psychopharmacologia       Date:  1962-03-12

5.  The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates.

Authors:  A HORITA; L J WEBER
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

6.  Cross tolerance between LSD and psilocybin.

Authors:  H ISBELL; A B WOLBACH; A WIKLER; E J MINER
Journal:  Psychopharmacologia       Date:  1961

7.  Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.

Authors:  D R Burt; I Creese; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

8.  Activity of a non-hallucinogenic ergoline derivative, lisuride, in an animal behavior model for hallucinogens.

Authors:  J L Marini; B L Jacobs; M H Sheard; M E Trulson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  On the specificity of a cat behavior model for the study of hallucinogens.

Authors:  J L Marini; M H Sheard
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

10.  The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.

Authors:  P B Silverman; B T Ho
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  7 in total

1.  Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.

Authors:  Danuta Marona-Lewicka; Ronald A Thisted; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2005-02-19       Impact factor: 4.530

Review 2.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 3.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

4.  Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.

Authors:  Marcus W Meinhardt; Cansu Güngör; Ivan Skorodumov; Lea J Mertens; Rainer Spanagel
Journal:  Neuropsychopharmacology       Date:  2020-05-05       Impact factor: 7.853

Review 5.  The promises and perils of psychedelic pharmacology for psychiatry.

Authors:  Tristan D McClure-Begley; Bryan L Roth
Journal:  Nat Rev Drug Discov       Date:  2022-03-17       Impact factor: 84.694

6.  Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.

Authors:  Adam L Halberstadt; Muhammad Chatha; Adam K Klein; Jason Wallach; Simon D Brandt
Journal:  Neuropharmacology       Date:  2020-01-07       Impact factor: 5.273

7.  How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.

Authors:  Manon van den Berg; Igor Magaraggia; Rudy Schreiber; Todd M Hillhouse; Joseph H Porter
Journal:  Psychopharmacology (Berl)       Date:  2022-03-29       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.